Company
Gi Windows
Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
0
510(k), De Novo and PMA
Device trials
14
As lead sponsor, any status
Adverse event reports
0
Received Nov 1, 2025 to Nov 19, 2026
Recall records
0
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
From SEC filings.
We found no SEC financing filings under the name Gi Windows, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Gi Windows.
Latest FDA decisions
No 510(k), De Novo or PMA decisions under this name since 2015.
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
- Megagon Magnet Anastomosis Plus OTOLoc for Creating Colo-colonic and Colorectal AnastomosesNot yet recruiting
NCT07856342 · 30 participants (planned) · Start Nov 16, 2026 · Primary completion Nov 30, 2026
Device: Megagon Self-Forming Magnet · For: Colo-rectal Anastomosis; Colo-rectal Cancer; Colo-rectal Surgery
NCT07695558 · 70 participants (planned) · Start Oct 27, 2026 · Primary completion Mar 2028
Device: Small Bowel Anastomosis · For: Small Bowel Anastomosis
Sites: Orlando, Florida; New Orleans, Louisiana; New York, New York · 4 sites in all
- Initial Safety of SFM Plus OTOLoc for Creating Side-to-side or End-to-side Colorectal AnastomosesRecruiting
NCT07276529 · 30 participants (planned) · Start Apr 1, 2026 · Primary completion Jun 2027
Device: Flexagon Self Forming Magnet Anastomosis Plus OTOLoc for Creating side-to-side Colon Anatomoses · For: Colorectal Cancer; Diverticular Diseases
Sites: Orlando, Florida; Houston, Texas
11 more trials with a free account
Reports received
0
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
No reports to chart for this view.
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
No device types to rank.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
No brand names to rank.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recalls under this name in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.